Click here for additional news beyond press releases.


Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000


October 29, 2009
Celera Licenses Lung Cancer Intellectual Property From Medical Therapies
October 28, 2009
Celera Corporation Reports Third Quarter 2009 Results
additional: Management Remarks for Third Quarter 2009 Earnings Call
October 28, 2009
Berkeley Heartlab Enters into Agreements with Proven Diagnostics and Geisinger Medical Center to Provide Testing for Cardiovascular Disease
October 21, 2009
Celera Corporation Third Quarter Fiscal 2009 Results and Conference Call Scheduled for October 28, 2009
September 29, 2009
Celera to Webcast Presentation at JMP Securities Healthcare Conference
September 22, 2009
Celera and Medco Enter Research Collaboration to Evaluate Effect of K1F6 Testing on Compliance with Statin Therapy in Patients with Cardiovascular Disease
September 2, 2009
Celera to Webcast its Presentation at Two Healthcare Conferences in September
August 6, 2009
Celera and Aurora Enter Collaboration for Use of Cardiovascular Genetics
August 6, 2009
Celera Corporation Reports Second Quarter 2009 Results
additional: Celera Corporation Teleconference August 6, 2009
Management Remarks for Second Quarter 2009 Earnings Call
August 4, 2009
Celera Presents Data Replicating its Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
July 22, 2009
Celera Announces Preliminary Second Quarter 2009 Revenue Results
June 29, 2009
Celera Grants License to Bayer Schering Pharma for Cancer-Related Targets
June 4, 2009
Celera to Webcast Presentation at the Eighth Annual Needham Life Sciences Conference on June 11, 2009
May 11, 2009
Celera to Webcast Presentation at the Eighth Annual JMP Securities Research Conference on May 18, 2009
May 6, 2009
Celera Corporation Reports First Quarter 2009 Results
additional: Celera Corporation Teleconference May 6, 2009
Management Remarks for First Quarter 2009 Earnings Call
April 30, 2009
Celera Appoints H. Robert Superko, M.D., as Vice President, Chief of Medical Affairs
April 29, 2009
Celera Presents Results Showing That Carriers of an LPA Gene Variant are at Elevated Risk of CHD Among Non-users of Aspirin, but not Among Aspirin Users
April 23, 2009
Celera Corporation First Quarter Fiscal 2009 Results and Conference Call Scheduled for May 6, 2009
April 23, 2009
deCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
April 23, 2009
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
April 21, 2009
Celera Presents Data Prescribing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
April 6, 2009
Celera Announces Chief Financial Officer Change
March 27, 2009
Celera and Collaborators Present Data Supporting the Suitability of a Prototype Fragile X Assay for Population Screening
March 23, 2009
Celera to Webcast Presentation as Part of the UBS West Coast Bus Tour on March 24, 2009
March 12, 2009
Celera and Collaborators Present Data Demonstrating the Association of Increased Risk for Heart Attack for Carriers with the KIF6 Gene Variant in a Hispanic Population from Costa Rica
March 11, 2009
Celera to Webcast Presentation at the Cowen Healthcare Conference on March 18, 2009
February 17, 2009
Celera Corporation Reports Fourth Quarter Calendar 2008 Results
additional: Celera Corporation Teleconference February 17, 2009 Management Remarks for Fourth Quarter Calendar 2008 Earnings Call
January 22, 2009
Celera Corporation Fourth Quarter Calendar 2008 Results and Conference Call Scheduled for February 17, 2009
January 14, 2009
Celera Announces the Appointment of K. Scott Bland as Vice President of Sales at Berkeley HeartLab
January 7, 2009
Celera to Webcast Presentation at JPMorgan Healthcare Conference